Company Profiles

driven by the PitchBook Platform

Athera Biotechnologies

Description

Developer of targeted anti-inflammatory drugs designed to create value by developing innovations from science into products that can be sold or out-licensed with high returns. The company's anti-inflammatory drug is used for the prevention and treatment of cardiovascular disease with proprietary clinical development stage program, enabling patients to lead a healthy life.

2005

Founded

PRIVATE

Status

1-10

Employees

2ndary - Private

Latest Deal Type

$2.82M

Latest Deal Amount

3

Investors

Description

Developer of targeted anti-inflammatory drugs designed to create value by developing innovations from science into products that can be sold or out-licensed with high returns. The company's anti-inflammatory drug is used for the prevention and treatment of cardiovascular disease with proprietary clinical development stage program, enabling patients to lead a healthy life.

Website:

www.athera.se

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

Sankt Eriksgatan 117 4th Floor 113 43 StockholmSweden +46 (0)7 619 38 190
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Athera Biotechnologies's full profile, request a free trial.

    Athera Biotechnologies Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Athera Biotechnologies Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    IndustrifondenVenture CapitalMinority000 0000000 0000
    Linc InvestOtherMinority000 0000000 0000
    ÖstersjöstiftelsenOtherMinority000 0000000 0000
    Industrifonden Venture Capital
    Linc Invest Other
    Östersjöstiftelsen Other

    Athera Biotechnologies Executive Team (4)

    NameTitleBoard
    Seat
    Contact
    Info
    Carina SchmidtChief Executive Officer
    Anders Bergman Ph.DVice President IP and Legal
    Knut Pettersson Ph.DVice President, Preclinical development
    Tommy AbrahamssonSenior Advisor CVD Pharmaceuticals
    Carina Schmidt Chief Executive Officer
    Anders Bergman Ph.D Vice President IP and Legal
    Knut Pettersson Ph.D Vice President, Preclinical development
    Tommy Abrahamsson Senior Advisor CVD Pharmaceuticals

    Athera Biotechnologies Board Members (3)

    NameRepresentingRoleSinceContact
    Info
    Gunnar Olsson Ph.DSelfChairman of the Board000 0000
    Jonas Brambeck Ph.DIndustrifondenInvestment Manager Life Science000 0000
    Svein Arild MathisenSelfBoard Member000 0000
    Gunnar Olsson Ph.D Chairman of the Board Self
    Jonas Brambeck Ph.D Investment Manager Life Science Industrifonden
    Svein Arild Mathisen Board Member Self
    Request full access to PitchBook